Audentes Therapeutics (BOLD) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free BOLD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsCompetitorsInsider TradesSocial MediaStock AnalysisAnalyst ForecastsCompetitorsInsider TradesSocial Media Audentes Therapeutics Short Interest DataCurrent Short Volume1,700,000 sharesPrevious Short Volume1,650,000 sharesChange Vs. Previous Month+3.03%Dollar Volume Sold Short$101.95 millionShort Interest Ratio / Days to Cover1.3Last Record DateJanuary 15, 2020Outstanding Shares46,272,000 sharesFloat Size41,610,000 sharesShort Percent of Float4.09%Today's Trading Volume154,924 sharesAverage Trading Volume1,504,389 sharesToday's Volume Vs. Average10% Short Selling Audentes Therapeutics ? Sign up to receive the latest short interest report for Audentes Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBOLD Short Interest Over TimeBOLD Days to Cover Over TimeBOLD Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Audentes Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20201,700,000 shares $101.95 million +3.0%4.1%1.3 $59.97 12/31/20191,700,000 shares $101.73 million +3.0%4.1%1.3 $59.84 BOLD Short Interest - Frequently Asked Questions What is Audentes Therapeutics' current short interest? Short interest is the volume of Audentes Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 1,700,000 shares of BOLD short. 4.09% of Audentes Therapeutics' shares are currently sold short. Learn More on Audentes Therapeutics' current short interest. What is a good short interest ratio for Audentes Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BOLD shares currently have a short interest ratio of 1.0. Learn More on Audentes Therapeutics's short interest ratio. What is a good short interest percentage for Audentes Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.09% of Audentes Therapeutics' floating shares are currently sold short. Is Audentes Therapeutics' short interest increasing or decreasing? Audentes Therapeutics saw a increase in short interest in January. As of January 15th, there was short interest totaling 1,700,000 shares, an increase of 3.0% from the previous total of 1,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Audentes Therapeutics' float size? Audentes Therapeutics currently has issued a total of 46,272,000 shares. Some of Audentes Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Audentes Therapeutics currently has a public float of 41,610,000 shares. How does Audentes Therapeutics' short interest compare to its competitors? 4.09% of Audentes Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Audentes Therapeutics: Alector, Inc. (9.48%), C4 Therapeutics, Inc. (13.94%), Taysha Gene Therapies, Inc. (8.59%), Fate Therapeutics, Inc. (16.62%), Humacyte, Inc. (4.38%), Exscientia plc (3.70%), Editas Medicine, Inc. (22.81%), Valneva SE (0.07%), Allogene Therapeutics, Inc. (29.95%), Voyager Therapeutics, Inc. (6.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($19.32 billion), Charter Communications, Inc. ($5.12 billion), Advanced Micro Devices, Inc. ($4.72 billion), Microchip Technology Incorporated ($3.73 billion), Match Group, Inc. ($2.38 billion), Snap Inc. ($2.17 billion), Wayfair Inc. ($2.11 billion), Uber Technologies, Inc. ($2.09 billion), Omnicom Group Inc. ($2.05 billion), and Hormel Foods Co. ($1.85 billion). View all of the most shorted stocks. What does it mean to sell short Audentes Therapeutics stock? Short selling BOLD is an investing strategy that aims to generate trading profit from Audentes Therapeutics as its price is falling. BOLD shares are trading up $1.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Audentes Therapeutics? A short squeeze for Audentes Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BOLD, which in turn drives the price of the stock up even further. How often is Audentes Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BOLD, twice per month. The most recent reporting period available is January, 15 2020. More Short Interest Resources from MarketBeat Related Companies: ALEC Short Interest CCCC Short Interest TSHA Short Interest FATE Short Interest HUMA Short Interest EXAI Short Interest EDIT Short Interest VALN Short Interest ALLO Short Interest VYGR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BOLD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings